Template:Cholecystitis Antibiotics: Difference between revisions

(Fix disease parameter: Acute calculous cholecystitis (canonical name, Cholecystitis redirects there))
(Add pediatric dosing section)
 
Line 19: Line 19:
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Doripenem|dose=500mg IV q8hrs|context=Complicated}}
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Doripenem|dose=500mg IV q8hrs|context=Complicated}}
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Meropenem|dose=1g IV q8hrs|context=Complicated}}
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Meropenem|dose=1g IV q8hrs|context=Complicated}}
====Pediatric====
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Ceftriaxone|dose=50-75mg/kg IV daily (max 2g)|context=Pediatric|population=Pediatric}} + {{AntibioticDose|disease=Acute calculous cholecystitis|drug=Metronidazole|dose=7.5mg/kg IV q8hrs (max 500mg)|context=Pediatric|population=Pediatric}} '''OR'''
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Piperacillin/Tazobactam|dose=80-100mg/kg IV q6-8hrs (max 4.5g)|context=Pediatric|population=Pediatric}} '''OR'''
*{{AntibioticDose|disease=Acute calculous cholecystitis|drug=Meropenem|dose=20mg/kg IV q8hrs (max 1g)|context=Pediatric Complicated|population=Pediatric}}

Latest revision as of 13:20, 20 March 2026

Most often isolated organisms are Escherichia coli, Klebsiella pneumonia, and anaerobes, especially Bacteroides fragilis

Uncomplicated

Pathogenicity of Enterococci remains unclear and specific coverage is not routinely suggested for community-acquired infections[1]

Complicated or Healthcare Associated

Examples of complication include severe sepsis or hemodynamic instability

  • Vancomycin 15-20mg/kg PLUS any of the following options

Options:

Pediatric

  1. Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5